PlainBillCongress, translated.Legislation. Context. Public interest.

Medicare Prescription Drug Price Negotiation Act of 2007

For Previous Action See H.R.4.

Official summary

Version 00 · Introduced in House · Jan 5, 2007

Medicare Prescription Drug Price Negotiation Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act to require the Secretary of Health and Human Services to negotiate with pharmaceutical manufacturers the prices that may be charged to prescription drug plan sponsors and Medicare Advantage organizations for covered part D drugs for part D eligible individuals enrolled under a prescription drug plan or under a Medicare Advantage prescription drug (MA-PD) plan.

Read the summary on Congress.gov
PlainBill analysis is coming later. This page presents official source data. We have not yet published a PlainBill explanation for this bill.

Who introduced it

Rep. Dingell, John D. [D-MI-15] · D–MI

Committees

  • Finance Committee
  • Ways and Means Committee
  • Energy and Commerce Committee
198 cosponsorship records, including any withdrawals

Actions

A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.

  1. For Previous Action See H.R.4.

  2. Received in the Senate and Read twice and referred to the Committee on Finance.

  3. On passage Passed by recorded vote: 255 - 170 (Roll no. 23). (text: CR H440)

    House roll call 23 · Individual votes
  4. Motion to reconsider laid on the table Agreed to without objection.

  5. Passed/agreed to in House: On passage Passed by recorded vote: 255 - 170 (Roll no. 23).(text: CR H440)

    House roll call 23 · Individual votes
  6. On motion to recommit with instructions Failed by the Yeas and Nays: 196 - 229 (Roll no. 22).

    House roll call 22 · Individual votes
  7. The previous question on the motion to recommit with instructions was ordered without objection. (consideration: CR H488)

  8. Floor Summary: DEBATE - The House proceeded with 10 minutes of debate on the Barton motion to recommit with instructions. The instructions contained in the motion seek to require the bill to be reported back to the House with an amendment inserting provisions assuring continued access to covered part D drugs and pharmacy networks and protection against increasing drug prices for veterans.

  9. Mr. Barton (TX) moved to recommit with instructions to Ways and Means and Energy and Commerce. (consideration: CR H486-488; text: CR H486)

  10. The previous question was ordered pursuant to the rule. (consideration: CR H486)

  11. DEBATE - Pursuant to the provisions of H. Res. 6, the House proceeded with three hours of debate on H.R. 4.

  12. Considered pursuant to H. Res. 6. (consideration: CR H440-489)

  13. Sponsor introductory remarks on measure. (CR E50)

  14. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  15. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  16. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  17. Introduced in House

  18. Introduced in House

Bill text & related measures

Text links open the official source. We currently store references to these documents.

Related bills identified by Congress.gov

Source last updated: Apr 7, 2025. Consult Congress.gov for the current record.

Explore the bill from different angles

Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.

Neutral evidence review

Objective

Analyze H.R.4 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.

View full prompt & sources
Fairness and public impact

Progressive lens

Examine H.R.4 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.

View full prompt & sources
Institutions and government scope

Conservative lens

Examine H.R.4 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.

View full prompt & sources
Individual rights and government power

Liberty lens

Examine H.R.4 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.

View full prompt & sources